Scientists probe immune System's secret battle after leukemia radiation
NCT ID NCT05035706
Summary
This study aims to understand how the body's immune system responds to leukemia tumors after they receive standard low-dose radiation treatment. Researchers will take small tissue samples and blood from about 10 adult patients with a type of blood cancer called acute myeloid leukemia before and after their radiation therapy. The goal is to gather information that could help doctors decide if adding treatments that boost the immune system (immunotherapy) might be beneficial for future leukemia patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.